MENU

OUR STORY

Molekule was incorporated with the notion that “good” and the “status quo” were inadequate.

Born out of a vision to create a firm combining an ethos of strategic & actionable competitive insight with industry leading dedication to clients, Molekule Consulting was founded in 2012 by David Alderman.

In 2017 Dr. Daniel Pascheles joined forces to nurture Molekule as a specialist management consultancy and a trusted partner of biopharmaceutical and life sciences players worldwide.
Molekule seeks to align intelligence outcomes, focus results, and enable our client partners to “win” in a highly dynamic and competitive environment.

Molekule is one of the few competitive intelligence consultancies dedicated solely to the CI space in the biopharmaceutical sector.

THE MOLEKULE WAY

VISION
We aspire to be the premier competitive intelligence and strategy consulting company in the life sciences industry delivering actionable insights and recommendations to our clients, essential for decision making, strategy development, and execution.
We aspire to be the premier competitive intelligence and strategy consulting company in the life sciences industry delivering actionable insights and recommendations to our clients, essential for decision making, strategy development, and execution.
VALUE
Molekule Consulting is a proactive and dedicated partner that leverages its industry leading CI expertise, deep area knowledge and its extensive global network to provide world-class competitive intelligence and strategy services.
Molekule Consulting is a proactive and dedicated partner that leverages its industry leading CI expertise, deep area knowledge and its extensive global network to provide world-class competitive intelligence and strategy services.
GUARANTEE
As a trusted consultant, Molekule conducts its business in an ethical manner with the highest level of integrity. Molekule Consulting will never compromise on these values.
As a trusted consultant, Molekule conducts its business in an ethical manner with the highest level of integrity. Molekule Consulting will never compromise on these values.

Global Presence

The Molekule team has a global footprint with significant “boots on the ground” presence across continents.
Worldwide
Headquarters
Miami, FL
Offices
New York, NY
Europe presence has been built-out to better accommodate our European client base
Headquarters
Zurich, CH
India presence consists of full-time staff supporting our global business
Headquarters
New Delhi, IN

Code of conduct

We commit

Molekule is committed to the highest standard of ethics throughout its global offices and worldwide consulting staff.

WE COMPLY

Molekule strictly complies with all global, regional, national and local laws and regulations pertinent to primary human source intelligence.

WE FOLLOW

Molekule complies with all SCIP rules, regulations and guidelines, globally, across all office locations and human capital resources.

WE EXECUTE

Molekule is committed to quality and integrity in all that we do, from how we safeguard client data to how we strive to continuously improve our performance.

TEAM PROFILES

Growing from strength to strength, the Molekule team is proud to have 180+ years of combined experience “within-the-walls” of Blue Chip pharma and generics competitive insights functions, including group leadership.
Our team brings with it a depth and breadth of functional, therapy area, and industry expertise that is rare among management consultancies.
David Alderman
President & Partner
Learn More
Dr. Daniel Pascheles
CEO & Partner
Learn More
Dr. Michael Marlatt
Vice President & Head of New York Office
Dr. Mark Powzniuk
Associate Vice President & Head of Oncology & Specialty Business Unit
Dr. Oleh Denysyk
Associate Vice President
Jayant Rana
Director & Head of India Office
Learn More
Dr. Mridul Das
Director
Learn More
Dr. Noah Wolfson
Director
Learn More
Drew Fussner
Director
Learn More
Dr. Paul Nunzio De Santis
Director
Learn More
Dr. Neha Dalmia
Director
Learn More
David founded Molekule Consulting with an ethos of strategic and actionable competitive insight combined with client centricity. He is responsible for numerous engagements with varied scopes and objectives in the competitive intelligence and primary market research areas. Project scopes range from pre-clinical through launch and lifecycle management (“LCM”) to supporting clients in clinical and commercial strategy development.
His major therapy expertise is in oncology, ophthalmology, cardiovascular, diabetes, autoimmune, and CNS. David attends numerous major medical congresses and scientific congresses globally.
Therapy Area & Subject Matter Expertise
Competitive Simulation Workshops
Generics & Biosimilars
Pre- & Peri-LOE Strategy
Cardiovascular
Manufacturing & Supply Chain Intelligence
Oncology
Ophthalmology
CDN
Go-to-Market Strategy
Cardiovascular
Sales Force size structure
Immunology &Inflammation
Dr. Pascheles joined Molekule Consulting in early 2017 as Chief Executive Officer and has over 20 years of experience in building world-class global competitive intelligence. As manager of large CI teams at Merck/MSD, Aventis and other healthcare companies, Daniel oversaw and led during his successful career in the pharmaceutical industry hundreds of primary CI projects, competitive simulations and strategic planning sessions.
Dr. Pascheles studied Pharmacy at the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland. He is a well-known speaker/chairman of International Conferences on Competitive Intelligence and Visiting Professor at the Rey Juan Carlos University in Madrid teaching a Master Class in CI.
Therapy Area & Subject Matter Expertise
Competitive Simulations & Strategic Planning
Generics & Biosimilars
Pre- & Peri-LOE Strategy
Early Warning Programs& Monitoring
Competitive Benchmarking
CI Process Consulting &CI Training
Cardiovascular
Michael is a uniquely experienced competitive intelligence (CI) professional and therapeutic area expert, who joined Molekule in 2017, where he has since led high-impact engagements across domains. Stylistically, he brings first-hand experience, rigorous attention to delivery, and lateral thinking to the management team and client engagements.
Mike began his career in Neuroscience Drug Discovery at Merck Research Labs. Following a PhD in the same field, completed at the University of Amsterdam and National Institutes of Health, he joined Deallus Consulting and was subsequently recruited to Occam Global, prior to joining Molekule.
Therapy Area & Subject Matter Expertise
Competitive Simulation Workshops
Immunology & Inflammation
Pre- and Peri-LOE Strategy
Regulatory Strategy
Life Cycle Management
Sales Force size structure
Rare Diseases
Diagnostics
Oncology
Virology
CNS
Dr. Mark Powzaniuk joined Molekule Consulting after spending 19 years within the pharmaceutical industry. As a seasoned pharmaceutical professional, he brings a unique background of science and business acumen. His experiences include Basic Research, Project Management, and Finance. Most recently, Mark was head of Global Competitive Intelligence, Oncology at Merck.
Mark started his career as a Post-Doctoral Research Fellow in the Bone Biology Department at Merck. After completing his fellowship, he joined Merck Project Management with increasing roles of responsibility, gaining both clinical and commercial experience. While obtaining his M.B.A., Mark transitioned to Business Integration and Finance. After a successful finance career, Mark joined Competitive Intelligence at Merck.
Therapy Area & Subject Matter Expertise
Competitive Intelligence Strategy and Processes
Oncology
Immuno-Oncology
Vaccine
Business Development and Licensing
Project Management
Competitive Intelligence Strategy & Processes
Life Cycle Management
Neuroscience
Oleh is a skilled competitive and business intelligence professional and a leader with an integrated background in biopharmaceuticals and healthcare. Having played key roles on the client side, he brings a keen knowledge of market and competitive intelligence expected by his clients and their internal partners including senior management. He is responsible for numerous engagements with varied scopes and objectives and assists in leading Strategic Competitive Simulation Workshops for clients. Oleh maintains his pharmacist license in two jurisdictions.
He practiced in hospital, long-term care and retail settings as the Pharmacist In Charge and was invited to join the Rho Chi Pharmacy Honor Society. He brings a holistic approach, using the 5-Forces Model, in obtaining actionable HUMINT (Human Intelligence) to help his clients make key decisions. Oleh is multilingual and attends numerous medical and scientific congresses globally.
Therapy Area & Subject Matter Expertise
Licensing & Business Development
Atypical Antipsychotics
Market Access/ Reimbursement
Endocrinology
Organ Transplantation
Ophthalmology
Autoimmune Diseases
Diagnostics
CNS
Bone Disease
Hematology
Regenerative Medicine
Oncology
Jayant is a CI expert adept in generating market and competitor insights. He joined Molekule in 2016 after significant blue chip pharma experience.

At Novartis, Jayant delivered insights to global and country brand teams across the globe in support of multiple blockbuster brands. At Abbott, Jayant supported the leadership team in diverse projects related to SFE, CRM, and business analytics to achieve strategic objectives profitably and sustainably.
At Lilly, Jayant developed market research expertise in support of the Diabetes brand team.

By academic training, Jayant is a biotechnology engineer and holds an MBA from the Indian Institute of Foreign Trade (IIFT).
Therapy Area & Subject Matter Expertise
Sales Force Effectiveness
Emerging Markets
Immunology
Generics & Biosimilars
Hematology
Diabetes
Competitive Analysis
Neurology
Respiratory
Cardiology
Mridul is a Director at Molekule Consulting. He started his career as a physician and holds an MBA degree from Amity University and is Six Sigma Green Belt certified from British Standards Institution. After a brief stint at AIIMS, he moved to strategy consulting and spent ten years across various organizations like Deloitte, Global Data, and Smart Analyst.
Therapy Area & Subject Matter Expertise
Business Development & Licensing
Prioritization (Assets & Indications)
Infectious Diseases
Portfolio Management (Optimization)
Competitive Intelligence
Rare Diseases
Commercial Opportunity Assessment
Oncology
Renal Diseases
Dr. Noah Wolfson has extensive experience as a research scientist in academic and government settings. After earning his PhD, Noah began his industry career at Flagship Ventures as a summer fellow before spending subsequent years at Ophthotech Corporation where he managed the development of various lifecycle and pipeline products. Most recently, Noah came from his consulting firm, Wolfson Scientific Consulting, where he worked to perform due diligence, drug development, and IP creation.
Noah completed his BS at Brandeis University in Biochemistry and completed his PhD in Biochemistry as a National Science Foundation Graduate Fellow at the University of Michigan.

Noah brings his extensive his background in biochemistry and experience in a range of fields which include ophthalmology, oncology, immunology, and rare diseases into each project.
Therapy Area & Subject Matter Expertise
Cardiovascular
Life Cycle Management
Infectious Diseases
IP & Regulatory Strategy
Medical Devices
Oncology
Drug Discovery & Design
Due Diligence
Go-to-Market Strategy
Generics & Biosimilars
Ophthalmology
Drew joined Molekule Consulting after spending 19 years within the pharmaceutical industry. He has a unique breadth of knowledge spanning science, manufacturing, and strategic marketing. He provides insightful market intelligence, product evaluations, and strategic recommendations based on past experiences in portfolio management. Prior to Molekule Drew held progressive roles at Mallinckrodt Pharmaceuticals / Covidien in Strategic Marketing and R&D.
Drew started his career in R&D at Covidien, Pfizer (King), and the U.S. FDA. After completing his M.B.A., he transitioned to Strategic Marketing and was responsible for pipeline product sections, product management, commercial launches, and evaluation of BD&L opportunities as the lead of generic portfolio competitive intelligence.
Therapy Area & Subject Matter Expertise
Generics & Biosimilars
Manufacturing Intelligence
Supply Chain Logistics Intelligence
CNS
Device Combination Products
Portfolio Management / Product Selection
Strategic Planning Cycle
Project Management
Forecasting & Modeling
Dr. Paul De Santis, PharmD joined Molekule Consulting after spending 4 years as a GLG special council member in Immuno-Oncology and Cell Therapy consulting for several of the largest global Private Equity and Hedge Funds with more than $10B in assets under management. During this time clients leveraged his depth of expertise on commercial dynamics operating within the Cell and Gene Therapy landscape to perform deep-dive addressable market analyses and leveraged his clinical expertise to understand an assets probability of regulatory and commercial success in support of valuation analysis.
In addition, he supported pre-commercial planning for several CAR T companies leveraging these skillsets to develop commercialization strategies that can maximize patient access to autologous cell therapies. Dr. De Santis provides deep expertise across the hematology/oncology and immuno-oncology landscapes and this is supported by 4 years of clinical training and 5 years of translational oncology research.
Therapy Area & Subject Matter Expertise
Immuno-Oncology (Large & Small Molecules)
Generics & Biosimilars
Addressable Market Analysis
Car-T/Adoptive Cellular Therapies
Molecular Diagnostic
Advanced Forecasting
Immunology
Discounted Cash Flow Valuation
Physician Education
Pricing & Market Access
M&A Valuation And Analysis
Commercial Analytics
Dr. Neha Dalmia joined Molekule with >13 years of scientific and business experience, having a unique ability to synthesize complex datasets into actionable insights. She has >5 years of market research, business strategy, and competitive intelligence (CI) experience in diverse therapeutic areas including immunology, oncology, biosimilars, and CNS. 
She also brings significant experience regarding innovation for in vitro diagnostics, social
media monitoring, and mentorship, having supported more than 60 startups in the medical devices and digital health field as part of the MedTech Innovator Accelerator, and having previously led development of PulseTraQ, within TheratraQ, building two service-based offerings for research on various social media platforms.
Therapy Area & Subject Matter Expertise
Oncology
Clinical Development
Forecasting & Modeling
Immunology
Diagnostics
CI Process Consulting & CI Training
Generics & Biosimilars
Sales Force Effectiveness
Digital Healthcare
Social Media Listening
Lifecycle Management
crosscross-circle
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram